It has been reported that CHMFL-FLT3-122 is a potent oral FLT3 kinase inhibitor that can be used to study FLT3-ITD-positive acute myeloid leukemia. CHMFL-FLT3-122 significantly inhibited tumor growth in a xenograft model of MV4-11 cells without significant toxicity in vivo.
- Size: 1mg
- Purity: ≥98%
- Molecular Formula: C 2 6 H 2 9 N 7 O 2
- Molecular Weight: 471.55
- Physical State: White to off-white Solid
- Storage: Powder:-20℃, 2 years;Insolvent(Mother Liquid):-20℃, 6 months;-80℃, 1 year
- Brand: Saint Michael
- Catalogue No.: ICA12470-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review